DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
NEPRILYSIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
NEPRILYSIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPROFLOXACIN; DEXAMETHASONE
4
Combination
Approved
OTHER
OTIC
Unknown
Unknown
CIPROFLOXACIN; DEXAMETHASONE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KETOBEMIDONE HYDROCHLORIDE
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
KETOBEMIDONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
MEPERIDINE HYDROCHLORIDE; PROMETHAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALCIUM; MEGLUMINE; METRIZOIC ACID
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
CALCIUM; MEGLUMINE; METRIZOIC ACID
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
SITAGLIPTIN PHOSPHATE;METFORMIN HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DIHYDROXYACETONE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DIHYDROXYACETONE
×
Maximum Phase:
4
First Approval:
None
UNII:
O10DDW6JOO
Molecule Type:
Small molecule
Molecular Formula:
C3H6O3
Molecular Weight:
90.08
AlogP:
-1.46
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IRON
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
IRON
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TRIFLUSAL
4
Small molecule
Approved
Unknown
Unknown
Insulin Resistance; Thrombosis
Unknown
TRIFLUSAL
×
Maximum Phase:
4
First Approval:
None
UNII:
1Z0YFI05OO
Molecule Type:
Small molecule
Molecular Formula:
C10H7F3O4
Molecular Weight:
248.16
AlogP:
2.33
PSA:
63.6
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FARICIMAB-SVOA
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
FARICIMAB-SVOA
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OUABAIN
4
Small molecule
Approved
Unknown
Unknown
Cardiovascular Diseases
Unknown
OUABAIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5ACL011P69
Molecule Type:
Small molecule
Molecular Formula:
C29H44O12
Molecular Weight:
584.66
AlogP:
-1.51
PSA:
206.6
HBD:
8.0
HBA:
#RotB:
4.0
Source:
ALUMINUM CHLOROHYDRATE
4
Unknown
Approved
Unknown
Unknown
Bone Diseases; Dermatitis; Kidney Diseases
Unknown
ALUMINUM CHLOROHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
HPN8MZW13M
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TULOBUTEROL
4
Small molecule
Approved
Unknown
Unknown
Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
TULOBUTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
591I9SU0F7
Molecule Type:
Small molecule
Molecular Formula:
C12H18ClNO
Molecular Weight:
227.74
AlogP:
2.76
PSA:
32.26
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
4
Combination
Approved
NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
ORAL
Unknown
Unknown
MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
METRIZOATE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
METRIZOATE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
O65Q227UIC
Molecule Type:
Small molecule
Molecular Formula:
C12H10I3N2NaO4
Molecular Weight:
649.92
AlogP:
3.14
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
3.0
Source:
INDIUM IN 111 CAPROMAB PENDETIDE
4
Antibody
Approved
Unknown
Unknown
Unknown
Diagnostic agent
INDIUM IN 111 CAPROMAB PENDETIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
COBICISTAT; DARUNAVIR ETHANOLATE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
COBICISTAT; DARUNAVIR ETHANOLATE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INTRINSIC FACTOR
4
Unknown
Approved
Unknown
Unknown
Anemia
Unknown
INTRINSIC FACTOR
×
Maximum Phase:
4
First Approval:
None
UNII:
70BT6OQT2Q
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XENON XE 133
4
Small molecule
Approved
Unknown
Unknown
Unknown
Diagnostic agent
XENON XE 133
×
Maximum Phase:
4
First Approval:
None
UNII:
X3P9A5HNYF
Molecule Type:
Small molecule
Molecular Formula:
Xe
Molecular Weight:
132.91
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
HUPERZINE A
4
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Substance-Related Disorders; Alzheimer Disease; Brain Injuries
Unknown
HUPERZINE A
×
Maximum Phase:
4
First Approval:
None
UNII:
0111871I23
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O
Molecular Weight:
242.32
AlogP:
2.0
PSA:
58.88
HBD:
2.0
HBA:
#RotB:
0.0
Source:
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
4
Combination
Approved
Unknown
ORAL
Unknown
Unknown
NALTREXONE HYDROCHLORIDE; OXYCODONE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NADROPARIN
4
Oligosaccharide
Approved
Unknown
Unknown
Unknown
Unknown
NADROPARIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Oligosaccharide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
HEMOPORFIN
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
HEMOPORFIN
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NOSCAPINE
4
Small molecule
Approved
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Cough
Unknown
NOSCAPINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8V32U4AOQU
Molecule Type:
Small molecule
Molecular Formula:
C22H23NO7
Molecular Weight:
413.43
AlogP:
2.88
PSA:
75.69
HBD:
0.0
HBA:
#RotB:
4.0
Source:
TISOTUMAB VEDOTIN-TFTV
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TISOTUMAB VEDOTIN-TFTV
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LACHESINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
LACHESINE
×
Maximum Phase:
4
First Approval:
None
UNII:
676774V4XX
Molecule Type:
Small molecule
Molecular Formula:
C20H26NO3+
Molecular Weight:
328.43
AlogP:
2.56
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
7.0
Source:
ACETAMINOPHEN; BUTALBITAL
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
ACETAMINOPHEN; BUTALBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CHLORQUINALDOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CHLORQUINALDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
D6VHC87LLS
Molecule Type:
Small molecule
Molecular Formula:
C10H7Cl2NO
Molecular Weight:
228.08
AlogP:
3.56
PSA:
33.12
HBD:
1.0
HBA:
#RotB:
0.0
Source:
Lamivudine; Nevirapine; Zidovudine
4
Combination
Approved
OTHER
ORAL
Unknown
Unknown
Lamivudine; Nevirapine; Zidovudine
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ETHINYL ESTRADIOL; LEVONORGESTREL
4
Combination
Approved
OTHER; PREGNANCY AND GYNECOLOGY
ORAL; ORAL-21; ORAL-28
Unknown
Unknown
ETHINYL ESTRADIOL; LEVONORGESTREL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMINO ACIDS; DEXTROSE
4
Combination
Approved
OTHER
INJECTION
Unknown
Unknown
AMINO ACIDS; DEXTROSE
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Combination
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BENPERIDOL
4
Small molecule
Approved
Unknown
Unknown
Anxiety; Dementia; Depressive Disorder; Schizophrenia; Psychotic Disorders
Dopamine D2 receptor antagonist
BENPERIDOL
×
Maximum Phase:
4
First Approval:
None
UNII:
97O6X78C53
Molecule Type:
Small molecule
Molecular Formula:
C22H24FN3O2
Molecular Weight:
381.45
AlogP:
4.18
PSA:
58.36
HBD:
1.0
HBA:
#RotB:
6.0
Source:
BUTAMBEN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Transient receptor potential cation channel subfamily A member 1 inhibitor
BUTAMBEN
×
Maximum Phase:
4
First Approval:
None
UNII:
EFW857872Q
Molecule Type:
Small molecule
Molecular Formula:
C11H15NO2
Molecular Weight:
193.25
AlogP:
2.23
PSA:
52.32
HBD:
1.0
HBA:
#RotB:
4.0
Source:
POLDINE
4
Small molecule
Approved
Unknown
Unknown
Digestive System Diseases
Unknown
POLDINE
×
Maximum Phase:
4
First Approval:
None
UNII:
8R92106W2F
Molecule Type:
Small molecule
Molecular Formula:
C21H26NO3+
Molecular Weight:
340.44
AlogP:
2.7
PSA:
46.53
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TRASTUZUMAB-PKRB
4
Unknown
Approved
Unknown
Unknown
Unknown
Unknown
TRASTUZUMAB-PKRB
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
291
292
293
294
295
296
297
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA